Executive Summary
Across 50 filings from Dow Jones 30-related streams, Q1 2026 results reveal mixed performance in banking with net income up 5-24% YoY on average but QoQ flat/down amid NIM fluctuations (e.g., +55bps YoY at Colony to -12bps at Bankwell) and deposit shifts; industrials shine with revenue surges of 15-30% YoY (Vertiv +30%, GE Vernova +16%, TE Connectivity +15%) driven by AI/power demand, though Wind segments lag. Biotech catalysts emerge with Kyverna's positive trial data in gMG/SPS, while SPACs like NewHold IV complete $201M IPOs and First Northern uplists to Nasdaq. Capital returns strong with dividends (e.g., FS Bancorp 53rd consecutive, BankUnited +6%) and buybacks ($60M at BankUnited, $1.4B at GE Vernova); 13F-HR filings (20+) show institutional tilt to tech giants (Apple, Nvidia, Microsoft), gold ETFs, and broad indices amid neutral sentiment. Guidance raises in industrials/healthcare (Vertiv to $13.5-14B sales, Elevance EPS $26.75+) signal resilience, but consumer loan declines (-2-4% QoQ) and operating losses flag risks. Portfolio-level: 6/10 banks mixed sentiment, 4/5 industrials positive/mixed with backlog growth, proxy-heavy governance routine.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from April 15, 2026.
Investment Signals(12)
- FS Bancorp↓(BULLISH)▲
Q1 net income $7.8M (-7% QoQ ex-BOLI but +YoY), book value +$0.87 QoQ to $42.42, 53rd dividend $0.29, merger completed, CRE loans +$17M QoQ
- GE Vernova↓(BULLISH)▲
Q1 revenue +16% YoY to $9.3B, orders +71% to $18.3B, backlog +$13B to $163B, raised 2026 guidance revenue $44.5-45.5B/EBITDA 12-14%, $1.4B returns
- COLONY BANKCORP↓(BULLISH)▲
Q1 net income +24% YoY to $8.2M, NIM +55bps YoY to 3.48%, loans +1.35% QoQ to $2.41B, dividend $0.12
- Bankwell Financial↓(BULLISH)▲
Q1 net income +24% QoQ to $11.3M, deposits +$113M QoQ (low-cost +$39M), SBA gains +$2.4M, dividend $0.20 payable May 19
- Vertiv Holdings↓(BULLISH)▲
Q1 sales +30% YoY to $2.65B (23% organic), adj margin +430bps to 20.8%, FCF +147% to $653M, raised FY26 sales $13.5-14B/EPS $6.30-6.40
- Elevance Health↓(BULLISH)▲
Q1 revenue +1.5% YoY to $49.5B, adj EPS $12.58 beat, raised FY26 EPS to $26.75+, $5.6B buyback left, dividend $1.72 Q2
- TE Connectivity↓(BULLISH)▲
Q2 FY26 sales +15% YoY to $4.74B (7% organic), adj EPS +24% to $2.73, orders +25% to $5.3B, Q3 guidance +10% sales/$2.83 EPS
- Travel & Leisure↓(BULLISH)▲
Q1 revenue +3% YoY, Adj EBITDA +20% to $191M, Gross VOI sales +7% to $549M, reaffirmed FY26 EBITDA $1.03-1.055B, $128M returns
- BankUnited↓(BULLISH)▲
Q1 net income +5.8% YoY to $61.9M, deposits non-brokered +$1.4B YoY, buyback $60M (1.3M shares), dividend +6% to $0.33
- Healthcare Services Group↓(BULLISH)▲
Q1 revenue +3.4% YoY to $462.8M, net income +52% to $26.1M, margins 12.1%/9.0%, $75M buyback thru Jan 2027
- HIVE Digital↓(BULLISH)▲
$100M 0% notes upsized (net $95M for GPUs/data centers), exchange premium 17.5% to $2.57/share
- NewHold Investment Corp IV↓(BULLISH)▲
$201M IPO closed +$6.4M private placement, $201M in trust
Risk Flags(9)
- FS Bancorp/Loan Trends↓[MEDIUM RISK]▼
Consumer loans -2.3% QoQ/-4.2% YoY to $583.5M, deposits flat QoQ
- GE Vernova/Wind Segment↓[HIGH RISK]▼
Wind revenue -23% YoY, EBITDA losses widen to -$0.4B on volumes/tariffs/losses
- Viomi Technology/Profitability↓[MEDIUM RISK]▼
Revenues +14.6% YoY but op income -17.8% YoY, expenses +24.6% on marketing +31.4%
- Brag House Holdings/Losses↓[HIGH RISK]▼
Net loss widens 383% YoY to $15.9M, zero revenue, op ex +417% to $7.7M
- Bankwell Financial/Metrics↓[MEDIUM RISK]▼
NIM -12bps QoQ to 3.28%, NPLs +$2.7M to 0.66%, nonint exp +$1.4M
- Elevance Health/Gains↓[HIGH RISK]▼
Op gain -34% YoY to $2.1B on $935M CMS accrual, Medicare Adv -15.8% YoY
- BankUnited/NIM↓[MEDIUM RISK]▼
NIM -7bps QoQ to 2.99% for 3rd quarter trend, non-int income -QoQ
- Travel & Leisure/Cash Flow↓[MEDIUM RISK]▼
Op cash $38M (-$83M YoY), Adj FCF neutral (-$152M YoY), Travel rev -8%
- Healthcare Services/Cash↓[LOW RISK]▼
Op cash ex-payroll -$8.7M YoY to $23.4M due to timing
Opportunities(10)
- GE Vernova/Prolec Acquisition↓(OPPORTUNITY)◆
$5.3B deal closed, Gas Power backlog 100GW targeting 110GW YE, Electrification 2.5 book-to-bill
- Vertiv/Guidance & Ratings↓(OPPORTUNITY)◆
Raised FY26 29-31% organic growth, net leverage 0.2x, inaugural IG ratings Baa3/BBB-
- First Northern/Nasdaq Uplist↓(OPPORTUNITY)◆
Approved for Nasdaq Capital Market listing effective April 24, 2026 from OTCQX
- Kyverna Therapeutics/Trial Data↓(OPPORTUNITY)◆
Positive KYSA-8 SPS primary analysis + KYSA-6 gMG follow-up, call April 22
- BankUnited/Capital↓(OPPORTUNITY)◆
CET1 12.2%, classified loans -12% QoQ, strong deposit growth
- Rafael Holdings/IP↓(OPPORTUNITY)◆
Exclusive MIT license for ApoE4 AD patent, Phase 3 NPC1 data Q3 2026
- TE Connectivity/Orders↓(OPPORTUNITY)◆
Record $5.3B Q2 orders +25% YoY across segments, FCF H1 +17%
- Healthcare Services/New Wins↓(OPPORTUNITY)◆
Revenue +3.4% on client wins/retention, $214M cash +$300M facility
- Everest Consolidator/Trust Amendment↓(OPPORTUNITY)◆
Allows interest withdrawal for expenses post-Jan 20, 2026 supporting extended search
- HIVE Digital/Capital Raise↓(OPPORTUNITY)◆
$95M net for GPUs/data centers, cap price $4.92/share
Sector Themes(6)
- Banking Mixed Recovery◆
5/6 banks net income +5-24% YoY avg +13% but QoQ flat/down, NIM +18-55bps YoY avg but -7-12bps QoQ in 3, deposits mixed (+$1.4B YoY BankUnited vs -$19M Colony); implies deposit competition eases but seasonal pressures persist
- Industrials/AI Power Boom◆
4 companies (Vertiv+30%, GE Vern+16%, TE+15%, backlog +$13B) revenue +15-30% YoY avg +20%, orders/book-to-bill >2x, guidance raised; data centers/Gas Power driving backlog to $163B+
- Biotech Trial Momentum◆
Kyverna/Rafael positive Phase 2/3 data in gMG/SPS/NPC1/AD (Q3 catalyst), IP strengthened; contrasts neutral healthcare proxies
- Capital Returns Acceleration◆
8/10 earnings filers dividends (e.g., 53rd consec FS Bancorp, +6% BankUnited) + buybacks ($60M BankUnited, $1.4B GEV, $75M HCSG), signaling conviction amid mixed ops
- Institutional Tech/Gold Tilt◆
20+ 13Fs heavy Apple/Nvidia/Microsoft (e.g., $18M Nvidia Decision, gold ETFs Fulcrum $25M+), broad ETFs; neutral but defensive shift amid volatility
- SPAC/Governance Routine◆
5 SPACs/IPOs active ($201M NewHold, RRE S-1, Everest amend), 8 proxies neutral (AGMs May-Jun) with equity plan hikes; low materiality but liquidity events
Watch List(8)
- Kyverna Therapeutics/Conference Call↓(IMMEDIATE)👁
Review KYSA-8 SPS + KYSA-6 gMG data, April 22 7am ET
- First Northern/Nasdaq Listing↓(NEAR-TERM)👁
Trading transition from OTCQX, effective April 24, 2026
- FS Bancorp/Dividend↓(NEAR-TERM)👁
Record date May 7, payment May 21, $0.29/share
- Bankwell/Dividend↓(NEAR-TERM)👁
Record May 8, payment May 19, $0.20/share
- Elevance Health/Q2 Dividend↓(NEAR-TERM)👁
$1.72/share payable June 25
- IIPR/Annual Meeting👁
June 9 8am PT, director elections + incentive plan vote [Q2]
June 3 3pm PDT virtual, director elections + fee pool +20% [Q2]
William Blair May 5-7, RBC May 20, others May/June for growth updates [Q2]
Filing Analyses(50)
22-04-2026
FS Bancorp reported Q1 2026 net income of $7.8 million ($1.02 per diluted share), down 7.1% QoQ from $8.4 million ($1.10) primarily due to the absence of a $1.0 million BOLI mortality benefit, but up slightly from $8.0 million ($1.01) YoY with pre-tax income growing 4.6% to $9.9 million. Total deposits excluding brokered CDs remained flat at $2.31 billion QoQ but increased 2.9% YoY, while loans receivable net were unchanged QoQ at $2.62 billion but rose 4.9% YoY; however, consumer loans declined 2.3% QoQ to $583.5 million and 4.2% YoY. The Board approved the 53rd consecutive quarterly cash dividend of $0.29 per share (record date May 7, 2026; payment May 21, 2026), repurchased $620,000 in shares, and highlighted the completed merger with Pacific West Bancorp in February 2026.
- ·Book value per share reached $42.42 at March 31, 2026, up $0.87 QoQ from $41.55 and $3.30 YoY from $39.12; tangible book value per share $40.61, up $0.96 QoQ and $3.65 YoY.
- ·Bank regulatory capital: total risk-based 13.8% and Tier 1 leverage 11.2% at March 31, 2026 (vs 14.0% and 11.0% at Dec 31, 2025).
- ·Commercial real estate loans grew $17.4 million QoQ to $986.8 million (37.2% of portfolio).
- ·83.3% of Q1 2026 consumer loan originations were home improvement loans with FICO score above 720.
22-04-2026
GE Vernova reported first quarter 2026 revenue of $9.3B, up 16% YoY (+7% organically), driven by strong equipment growth in Power (+12% revenue) and Electrification (+61% revenue), with total orders surging 71% organically to $18.3B and backlog expanding $13.0B sequentially to $163B. However, Wind segment revenue declined 23% YoY (-25% organically) with EBITDA losses widening to $(0.4)B due to lower Onshore Wind equipment volume, tariffs, and Offshore Wind contract losses. The company completed the Prolec GE acquisition for $5.3B, generated free cash flow of $4.8B, raised 2026 guidance for revenue to $44.5-$45.5B and adjusted EBITDA margin to 12%-14%, and returned $1.4B to shareholders.
- ·Gas Power equipment backlog and slot reservations grew to 100 GW total end Q1 2026, targeting at least 110 GW by year-end.
- ·Electrification book-to-bill ratio approximately 2.5 in Q1 2026.
- ·2026 guidance: Power organic revenue growth 16%-18%, segment EBITDA margin 17%-19%; Electrification revenue $14.0-$14.5B, margin 18%-20%; Wind organic revenue down low-double digits, EBITDA losses ~$400M.
- ·Capex $0.4B in Q1 2026, committed to $6B from 2025-2028; R&D $0.3B, committed to $5B from 2025-2028.
- ·Zero fatalities in Q1 2026.
22-04-2026
Viomi Technology Co., Ltd's annual report for the year ended December 31, 2025, shows consolidated total revenues of RMB 2,428,226 thousand (RMB 2.428 billion), up 14.6% YoY from RMB 2,118,982 thousand in 2024. However, income from operations declined 17.8% YoY to RMB 128,554 thousand due to total operating expenses rising 24.6% YoY to RMB 529,397 thousand, driven by sharp increases in selling and marketing expenses (+31.4%) and other categories. Net income attributable to the Company stood at RMB 141,644 thousand, roughly flat (-1.9%) compared to 2024 continuing operations net income of RMB 144,364 thousand, as 2024 totals were reduced by an RMB 80,950 thousand discontinued operations loss.
- ·Hypothetical taxation scenario assumes 25% statutory tax rate yielding 67.5% net distribution to parent/shareholders after 10% withholding tax.
- ·Certain subsidiaries and VIEs qualify for 15% preferential income tax rate in China, though temporary and subject to review.
- ·Inter-company revenues eliminated in consolidation: RMB 1,539 thousand in 2025 vs RMB 582,002 thousand in 2024.
- ·VIEs and subsidiaries reported net loss of RMB 411 thousand in 2025 vs net income contribution in 2024.
22-04-2026
Brag House Holdings, Inc. reported total assets increasing over 1,036% YoY to $14,788,299 as of December 31, 2025, driven by related party receivables and cash, turning stockholders' equity positive at $3,434,862 from a $8,456,285 deficit. However, the company posted a significantly widened net loss of $15,890,509 (up 383% from $3,288,519 in 2024) amid zero revenues, sharply higher operating expenses of $7,718,905 (417% YoY increase), and large non-cash charges including $3,908,891 change in fair value of warrants and convertible debt. Common shares outstanding diluted to 20,951,363 from 7,033,330, with EPS worsening to ($1.31) from ($0.58).
- ·Cash and Cash Equivalents increased to $222,572 from $29,228.
- ·Notes Receivable - Related Party: $8,779,000 as of Dec 31, 2025.
- ·Advances to Related Party: $3,365,000 as of Dec 31, 2025.
- ·Warrant Liability: $3,987,046 as of Dec 31, 2025.
- ·Net Unrealized Loss on Equity Securities: $2,900,000 in 2025.
- ·Change in Fair Value of Warrants and Convertible Debt: $3,908,891 loss in 2025.
- ·PIPE Offering: Issuance of Series B Convertible Preferred Stock with Warrants, net of $1,964,705 offering costs.
- ·IPO: Issuance of Common Stock net of $1,176,800 offering costs.
22-04-2026
Colony Bankcorp reported first quarter 2026 net income of $8.2 million, up 24% YoY from $6.6 million but only up 5% QoQ from $7.8 million, with operating net income at $9.5 million reflecting strong diversification gains. Loans grew 1.35% QoQ to $2.41 billion and net interest margin expanded to 3.48% from 2.93% YoY, however deposits fell $19.1 million QoQ to $3.05 billion amid seasonal outflows and noninterest expenses rose 37% YoY to $27.7 million due to acquisition costs. The board declared a quarterly cash dividend of $0.12 per share.
- ·Net interest margin improved to 3.48% in Q1 2026 from 2.93% in Q1 2025.
- ·Preliminary capital ratios at Mar 31, 2026: tier one leverage 9.84%, tier one risk-based 13.44%, total risk-based 15.75%, CET1 12.53%.
- ·Net charge-offs $1.7 million (0.29% of avg loans) in Q1 2026 vs $1.6 million (0.30%) in Q4 2025.
- ·Mortgage production $88.5 million and sales $61.4 million in Q1 2026, down from $89.5 million and $68.1 million in Q4 2025.
- ·SBSL closed $13.1 million and sold $10.4 million SBA loans in Q1 2026, down from $29.1 million and $16.8 million in Q4 2025.
22-04-2026
Bankwell Financial Group reported Q1 2026 GAAP net income of $11.3 million ($1.41 per diluted share), up from $9.1 million ($1.15 per share) in Q4 2025, driven by core deposit growth of $113 million (including $39 million in low-cost deposits) and net loan growth of $27.1 million. However, net interest margin declined 12 basis points to 3.28%, noninterest expense increased $1.4 million to $16.9 million, PPNR fell 10.2% to $13.3 million, and nonperforming loans rose $2.7 million to $19.0 million (0.66% of total loans). The board declared a $0.20 per share dividend payable May 19, 2026, to shareholders of record on May 8, 2026.
- ·SBA loan sale gains increased to $2.4 million in Q1 2026 from $2.2 million in Q4 2025.
- ·Opened first full-service branch in New York State on February 20, 2026, in Bay Ridge, Brooklyn.
- ·Brokered deposits declined $44.5 million (8.0%) and FHLB borrowings $50.0 million QoQ; reduced brokered deposits by $512.4 million (49.9%) since December 31, 2022 peak.
- ·Credit for credit losses - loans of $1.0 million in Q1 2026; ACL-Loans coverage of nonperforming loans at 155.39%.
- ·Guidance: non-interest expense $64-65M full year 2026; non-interest income increased to $12-13M.
- ·Conference call scheduled for April 23, 2026, at 9:00 a.m. ET.
22-04-2026
Innovative Industrial Properties, Inc. (IIPR) has issued a proxy statement for its annual stockholder meeting on June 9, 2026, seeking approval for the election of five directors (Alan Gold, Scott Shoemaker, Paul Smithers, David Boyle, and Bruce Ives), ratification of BDO USA, P.C. as independent auditors for the year ending December 31, 2026, adoption of the 2026 Omnibus Incentive Plan, and non-binding advisory votes on named executive officer compensation and the frequency of such votes (recommending one year). As of the record date April 10, 2026, 28,573,470 shares of common stock were outstanding out of 50,000,000 authorized, with a quorum requiring 14,286,735 shares; Gary Kreitzer will retire from the Board.
- ·Annual Meeting time: 8:00 a.m. Pacific Time at 11440 West Bernardo Court, Suite 100, San Diego, CA 92127
- ·Voting methods: Internet, telephone, or mail; in-person voting allowed
- ·Directors elected by plurality vote; other proposals by majority of votes cast
- ·Broker non-votes have no effect on non-routine matters (e.g., director election, incentive plan, advisory votes); auditor ratification is routine
22-04-2026
AVITA Medical's DEF 14A proxy statement for the June 3, 2026 Annual Meeting seeks stockholder approval for electing seven directors, ratifying Grant Thornton LLP as auditor for 2026, increasing the non-executive director annual cash fee pool from $750,000 to $900,000 (a 20% increase), specific RSU and option grants to non-executive directors (e.g., 22,214 RSUs and 16,133 options to several directors, higher for new appointees), advisory votes on executive compensation and frequency, issuance of warrants covering up to 650,000 shares to Perceptive Credit Holdings V, LP, and a 10% increase in placement capacity under ASX rules. As of the April 9, 2026 record date, 30,776,689 shares of Common Stock were outstanding. No financial performance metrics or period-over-period comparisons are provided in the filing.
- ·Annual Meeting held solely via remote webcast at meetnow.global/MXCFDJM on June 3, 2026 at 3:00 p.m. PDT (June 4, 2026 at 8:00 a.m. AEST).
- ·Credit Agreement with Perceptive dated January 13, 2026.
- ·Dr. Michael Tarnoff appointed August 6, 2025; Joseph Woody appointed January 1, 2026.
- ·Five CDIs represent one share of Common Stock.
- ·Broker non-votes apply to non-routine matters; only Proposal 2 (auditor ratification) is routine.
22-04-2026
Nuveen Churchill BDC V (BDC V) shareholders are voting at a special meeting on April 30, 2026, to approve the sale of substantially all assets and liabilities to affiliated Nuveen Churchill Private Capital Income Fund (PCAP) for cash equal to BDC V's net asset value as of the determination date (approximately $337,301,756 as of December 31, 2025), followed by withdrawal of BDC status under the 1940 Act, wind-down, dissolution, and liquidation to provide liquidity. The transaction transfers portfolio assets valued at $769,747,636 (excluding cash) and $468,500,000 in credit facility debt to PCAP, with the board unanimously recommending approval as in shareholders' best interests with no dilution. However, the transaction may result in taxable consequences for shareholders.
- ·Special Meeting record date: April 1, 2026
- ·Purchase Agreement dated April 1, 2026
- ·Net asset value to be determined within 48 hours prior to Effective Time
- ·Transaction approval requires majority of votes cast; Withdrawal Proposal requires lesser of 67% of shares present/represented (if >50% present) or >50% of outstanding shares
- ·Abstentions count as 'AGAINST' for Withdrawal Proposal
22-04-2026
NewHold Investment Corp IV, a blank check company, consummated its initial public offering (IPO) on April 16, 2026, selling 20,125,000 units at $10.00 per unit, generating gross proceeds of $201,250,000, including the full exercise of the underwriter's over-allotment option for 2,625,000 units. Simultaneously, the Company completed a private placement of 641,250 units at $10.00 per unit for aggregate proceeds of $6,412,500 to its Sponsor (440,000 units) and BTIG, LLC (201,250 units). A total of $201,250,000 from the net IPO proceeds and private placement was placed in trust, with the audited balance sheet as of April 16, 2026, showing total assets of $203,605,000 and shareholders' deficit of $5,287,000.
- ·Current assets outside trust: $2,355,000 (including cash $2,017,000, due from Sponsor $158,000, prepaid expenses $180,000)
- ·Current liabilities: $598,000 (accounts payable – offering costs $318,000, accrued expenses $280,000)
- ·Class A ordinary shares subject to redemption: 20,125,000 shares at $10.00 per share totaling $201,250,000
- ·Company incorporated October 6, 2025; fiscal year end December 31
22-04-2026
RRE Ventures Acquisition Corp., a blank-check SPAC, filed an S-1/A registration statement on April 22, 2026, for an IPO of 25,000,000 units (assuming no over-allotment and 1,250,000 founder shares surrendered), each comprising one Class A ordinary share and one-third of one warrant exercisable at $11.50 per share. Post-offering, the company expects 33,333,333 Class A ordinary shares and 15,343,333 warrants outstanding, including 8,333,333 public warrants, 4,510,000 private placement warrants to sponsor RRESponsor LLC, and 2,500,000 to the underwriter. The sponsor provided an initial $25,000 investment and holds founder shares, of which 2,748,000 Class B shares were sold to management and affiliates.
- ·Registration No. 333-294904
- ·Warrants exercisable 30 days after initial business combination completion; expire 5 years thereafter
- ·Warrant exercise price: $11.50 per share (adjustable under certain conditions to 115% of higher of Market Value or Newly Issued Price)
- ·Public warrants redeemable at $0.01 each if Class A share price >= $18.00 for 20 trading days in 30-day period (beginning 120 days post-business combination)
- ·Up to 1,250,000 founder shares subject to surrender based on underwriter over-allotment exercise
- ·Separate trading of shares and warrants prohibited until post-closing Form 8-K with audited balance sheet filed
22-04-2026
Vertiv Holdings Co reported strong Q1 2026 results with net sales of $2,650 million, up 30% YoY driven by 23% organic growth (44% in Americas), 4% from acquisitions, and 3% FX; adjusted operating profit rose 64% to $551 million with margin expansion of 430 bps to 20.8%. Operating cash flow increased 153% to $767 million and adjusted free cash flow up 147% to $653 million, with net leverage at 0.2x and liquidity at $5.0 billion. The company raised FY2026 guidance for net sales to $13,500-$14,000 million (29-31% organic growth) and adjusted diluted EPS to $6.30-$6.40 (51% growth at midpoint).
- ·Received inaugural investment grade ratings: Moody's Baa3 and S&P BBB- in February 2026.
- ·Retired outstanding term loan and ABL revolver in March 2026.
- ·Q2 2026 guidance: net sales $3,250M-$3,450M (20-24% organic growth), adjusted operating profit $690M-$730M (20.7-21.7% margin), adjusted diluted EPS $1.37-$1.43 (44-51% growth).
- ·FY2026 guidance also includes adjusted operating profit $3,140M-$3,260M (22.8-23.8% margin) and adjusted free cash flow $2,100M-$2,300M.
- ·Added to S&P 500 in March 2026.
22-04-2026
Wright Investors’ Service Holdings, Inc. filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025 (original filing March 30, 2026), adding Part III disclosures (Items 10-14) on directors, officers, compliance, and executive compensation, and updating Part IV Item 15 with Section 302 Sarbanes-Oxley certifications. No financial statements or modifications to prior financial disclosures are included; the original 10-K is incorporated by reference. The company is designated as a shell company and small business with a public float of $4 million and 20,620,711 shares of common stock outstanding.
- ·Entity is a shell company (true), small business (true), and non-accelerated filer.
- ·No Trading Symbol Flag: true.
- ·Entity address: 118 North Bedford Road, Ste. 100, Mount Kisco, NY 10549.
- ·Document Period End Date: Dec. 31, 2025; Filing Date: April 22, 2026.
22-04-2026
Elevance Health reported Q1 2026 operating revenue of $49.5 billion, up 1.5% YoY from $48.8 billion, driven by higher premium yields and CarelonRx growth, with adjusted diluted EPS of $12.58 exceeding expectations. However, operating gain fell 34.2% to $2.1 billion from $3.2 billion due to a $935 million CMS accrual, $129 million business optimization charge, and higher Medicaid medical costs, while key memberships like Medicare Advantage declined 15.8% YoY and Health Benefits operating gain dropped 2.7%. The company raised FY 2026 adjusted diluted EPS guidance to at least $26.75 and reaffirmed operating cash flow of at least $5.5 billion.
- ·Days in Claims Payable: 46.6 days as of Mar 31 2026, up 3.8 days YoY
- ·Q1 2026 dividend: $1.72 per share; Q2 dividend declared $1.72 per share payable June 25 2026
- ·Share repurchase authorization remaining: $5.6 billion as of Mar 31 2026
- ·CarelonRx quarterly adjusted scripts: 80.3 million, down 4.3% YoY
22-04-2026
Purple Innovation, Inc. (PRPL) filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 9, 2026, at 10:00 a.m. Mountain Time, seeking approval to elect eight directors, an advisory vote on executive compensation, and ratification of BDO USA, P.C. as independent auditors for the year ending December 31, 2026. The record date is April 13, 2026, with 108,825,636 Class A shares and 163,052 Class B shares outstanding, totaling 108,988,688 votes eligible. No financial performance metrics are discussed.
- ·Annual Meeting registration deadline: June 7, 2026, at 5:00 p.m. Eastern Time at https://register.proxypush.com/PRPL.
- ·Quorum requires majority of voting power of outstanding Common Stock.
- ·Proposal 1 (director election) and Proposal 2 (exec comp) are non-routine; brokers cannot vote uninstructed shares. Proposal 3 (auditor ratification) is routine.
- ·Proxy materials available at https://annualgeneralmeetings.com/prpl2026.
22-04-2026
Fearless Solutions, LLC dba Best Invest filed its 13F-HR on April 22, 2026, reporting 127 equity holdings as of March 31, 2026, all held with sole voting and dispositive power and no reported put or call options. The portfolio emphasizes ETFs, with top positions including PACER FDS TR US SMALL CAP CAS ($10.2M), ISHARES GOLD TR ISHARES NEW ($7.18M), PACER FDS TR US CASH COWS 100 ($7.1M), FIRST TR EXCHANGE-TRADED FD FIRST TR TA HIYL ($6.8M), and ISHARES TR RUSSELL 2000 ETF ($6.4M). Notable individual stock holdings include APPLE INC COM (30832 shares, $7.8M) and SCHWAB CHARLES CORP COM (37506 shares, $3.5M).
- ·All 127 positions held with sole shared voting and dispositive power (0 shared, 0 other managers).
- ·No put or call options reported.
- ·Firm address: 16118 Via Shavano, Suite 100, San Antonio, TX 78249.
- ·SEC file number: 028-25816.
22-04-2026
Shotwell Rutter Baer Inc, an institutional investment manager, filed its 13F-HR report on April 22, 2026, disclosing total holdings of $170,197,922 across 38 positions as of March 31, 2026, primarily consisting of ETFs focused on equities, international markets, ESG themes, and fixed income. Key holdings include Vanguard Total Stock Market ETF ($24,293,205), American Century US Large Cap Value ETF ($17,458,706), and Dimensional International Core Equity Market ETF ($13,792,279), with smaller positions in individual stocks such as Walmart ($677,187), IBM ($485,149), and Illinois Tool Works ($222,359). No period-over-period changes are provided in the filing.
- ·Filing period end date: March 31, 2026
- ·All positions reported as sole discretionary with no voting or shrunken shares authority
- ·White Mountains Insurance Group Ltd holding: 242 shares valued at $531,664
22-04-2026
MFA Wealth Services filed its 13F-HR form on April 22, 2026, disclosing 123 equity holdings as of March 31, 2026, with a total market value of $151,046,462. The portfolio is diversified across individual stocks such as Apple Inc (1,079,200 shares), Walmart Inc (1,090,900 shares), and Microsoft Corp (533,900 shares), as well as various ETFs including iShares Core S&P 500 ETF (2,206,500 shares). All reported positions are held under sole investment discretion.
- ·Business address: 100 E Thousand Oaks Blvd, Suite 258, Thousand Oaks, CA 91360
- ·All holdings under sole voting and investment discretion
- ·Report filed as non-amended (initial quarterly filing for period)
22-04-2026
Fund Resources Investment Holding Group Co Ltd, based in Hong Kong, filed a 13F-HR report as of March 31, 2026, disclosing a single holding of 9,440,418 shares of Bitdeer Technologies Group CL A ORD SHS (CUSIP: G11448100) valued at $81,659,616. The filing was submitted on April 22, 2026, by Director Cheung Ka Wai. No prior period comparisons or changes in holdings are detailed in this report.
- ·CUSIP for Bitdeer Technologies Group CL A ORD SHS: G11448100
- ·Report period end: March 31, 2026
- ·Filing SEC file number: 028-17108
22-04-2026
Kopin Corporation's DEF 14A proxy statement solicits votes for its 2026 Annual Meeting on May 21, 2026, including election of five directors for terms expiring at the 2027 meeting, approval of the amendment and restatement of the 2020 Equity Incentive Plan, ratification of BDO USA, P.C. as independent auditors for the fiscal year ending December 26, 2026, and advisory approval of named executive officer compensation for the fiscal year ended December 27, 2025. The record date is March 26, 2026, with 183,476,366 shares of common stock and 1,000 shares of Series A convertible preferred stock (convertible into 2,333,333 common shares) outstanding and entitled to vote. No financial performance metrics or period-over-period changes are detailed beyond standard governance disclosures.
- ·Meeting location: offices of Morgan, Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts 02110, at 10:00 a.m. Eastern Time
- ·Proxy materials mailed on or about April 20, 2026
- ·Internet and telephone voting closes at 11:59 p.m. ET on May 20, 2026
22-04-2026
HIVE Digital Technologies Ltd. announced the upsizing and pricing of a private offering of US$100 million aggregate principal amount of 0% exchangeable senior notes due 2031 (upsized from US$75 million), issued by its subsidiary HIVE Bermuda 2026 Ltd., with an option for initial purchasers to buy an additional US$15 million. The notes carry an initial exchange price of approximately US$2.57 per common share (17.5% premium to the April 16, 2026 Nasdaq closing price) and net proceeds of approximately US$95 million (or US$109.5 million if option exercised) will fund general corporate purposes, capital investments including GPUs, and data center development. The company also entered capped call transactions with a cap price of US$4.92 per share (125% premium to closing price), funded partly by US$17.2 million in cash on hand.
- ·Notes mature on April 15, 2031; exchangeable starting under certain conditions prior to January 15, 2031.
- ·Expected closing date: April 21, 2026, subject to customary conditions.
- ·Holders can require repurchase on April 15, 2029, or upon fundamental change.
- ·Issuer may redeem prior to April 20, 2029 only on tax events; after April 20, 2029 if share price >=130% of exchange price.
- ·Common shares expected to cease trading on TSXV and commence on TSX around April 30, 2026; TSX listing conditional by June 30, 2026.
- ·Capped call transactions to reduce dilution upon exchange, subject to anti-dilution adjustments.
22-04-2026
Montgomery Investment Management Inc. filed its 13F-HR on April 22, 2026, for the quarter ended March 31, 2026, disclosing 103 equity holdings under sole investment discretion with a mix of sole and none voting authority shares. Top positions by value include United Rentals Inc ($24792897), VSE Corp ($22806487), Truist Financial Corp ($14624482), Deere & Co ($14240224), and Apple Inc ($12456013), reflecting diversification across industrials, financials, technology, and energy sectors. No other managers reported; all holdings are SH (shares) with no puts or calls.
- ·Business address: 6229 Executive Boulevard, Rockville, MD 20852
- ·SEC file number: 028-10668
- ·All positions held with sole investment discretion and no puts/calls
22-04-2026
First Northern Community Bancorp, holding company of First Northern Bank, announced on April 21, 2026, that its common stock has been approved by Nasdaq for listing on The Nasdaq Capital Market, with trading to transition from OTCQX effective April 24, 2026, under the existing ticker 'FNRN'. Shareholders do not need to take any action. The press release is attached as Exhibit 99.1.
- ·Trading on OTCQX continues through end of day April 23, 2026.
- ·Subject to continued satisfaction of Nasdaq listing requirements.
- ·Filing signed April 21, 2026; filed April 22, 2026.
22-04-2026
Didier Papadapoulos, President of Aircraft OEM at Joby Aviation, Inc., notified the company of his resignation effective July 3, 2026, to spend time with family and pursue personal interests after five years leading aircraft development efforts. The departure is not due to any disagreement with the company, which expressed gratitude for his contributions and expects him to provide ongoing advisory services.
- ·Resignation notification date: April 20, 2026
- ·Filing signed on April 21, 2026
- ·SEC filing date: April 22, 2026
22-04-2026
Decision Investments, Inc. filed its 13F-HR on April 22, 2026, disclosing U.S. equity holdings as of March 31, 2026, totaling $87,934,619 across 140 positions, all held with sole voting and dispositive power. The portfolio is heavily concentrated in technology stocks and ETFs, with the largest holding in NVIDIA CORP at $18,747,128 (107,495 shares), followed by Lam Research Corp at $5,247,276 (24,559 shares) and Apple Inc. at $3,723,738 (14,673 shares). No changes, short positions, or options are indicated in the filing.
- ·Filing period end date: March 31, 2026
- ·All positions reported as SH SOLE with no shared voting/dispositive power, puts, calls, or other manager categories
- ·Company address: 4445 Eastgate Mall, Ste 200, San Diego, CA 92121
22-04-2026
Kyverna Therapeutics, Inc. issued a press release on April 21, 2026, announcing positive primary analysis results from its registrational trial KYSA-8 evaluating miv-cel (mivocabtagene autoleucel, KYV-101) in stiff person syndrome (SPS). The company will host a conference call at 7:00 a.m. Eastern Time on April 22, 2026, to review the results. No financial or comparative performance metrics were disclosed.
- ·Filed under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
- ·Press release furnished as Exhibit 99.1
22-04-2026
Sherrill & Hutchins Financial Advisory, Inc. filed its quarterly 13F-HR report as of March 31, 2026, disclosing total portfolio holdings valued at $169303049 across 15 positions, all held with sole investment discretion. Top holdings by value include Vanguard Scottsdale Fds VNG Rus1000Idx at $46482996, Fidelity Merrimack Str Tr Total Bd ETF at $41312517, and American Centy ETF Tr US Sml Cp Valu at $33816788. No period-over-period changes or performance metrics are provided in the filing.
- ·Filing submitted on April 22, 2026, for period ended March 31, 2026
- ·All positions held with SOLE investment discretion
- ·Central Index Key: 0002005607
- ·SEC File Number: 028-23510
22-04-2026
Oak Wealth Advisors LLC filed its 13F-HR on April 22, 2026, reporting holdings as of March 31, 2026, consisting of 58 positions with a total value of $182,000,176. The portfolio is diversified across ETFs from American Century, Dimensional, Vanguard, iShares, PIMCO, and select individual stocks including Microsoft, Apple, Berkshire Hathaway, Amazon, Nvidia, and Eli Lilly. No period-over-period changes or performance metrics are disclosed in the filing.
- ·Filing period end date: March 31, 2026
- ·Date as of change: April 21, 2026
- ·Business address: 836 Skokie Blvd, Northbrook, IL 60062
- ·Phone: 8479458888
- ·SEC file number: 028-25230
22-04-2026
Everest Consolidator Acquisition Corporation filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, modifying Section 9.1(b) of Article IX to permit withdrawal of interest earned on the Trust Account on or after January 20, 2026, for Permitted Expenses including taxes, legal costs, insurance, audits, and working capital related to seeking a business combination. The amendment was adopted by the Board of Directors and approved by stockholders in accordance with Delaware law. This change enhances liquidity access without releasing principal, supporting extended operations toward a potential business combination.
- ·Original Certificate of Incorporation filed: March 8, 2021
- ·Amended and Restated Certificate filed: November 23, 2021
- ·Amendment signed: April 20, 2026
- ·Registration Statement initially filed: October 18, 2021
22-04-2026
Fulcrum Wealth Advisors, LLC filed its 13F-HR on April 22, 2026, reporting holdings as of March 31, 2026, with a total portfolio market value of $120,782,731 across 72 positions held with sole voting and investment discretion. Top holdings include ETFS Gold TR Physical Gold Shs ($13,424,507), Sprott Physical Gold TR ($12,090,427), Microsoft Corp. ($7,710,244), and Vanguard Intl Equity Index F FTSE Europe ETF ($6,936,320), reflecting heavy exposure to gold ETFs and large-cap tech and index funds. No changes from prior periods or performance metrics were disclosed in the filing.
- ·Filing CIK: 0002108790
- ·SEC File Number: 028-26047
- ·Business Address: 10940 NE 33rd Place, Suite 210, Bellevue, WA 98004
- ·Phone: 425-250-6280
22-04-2026
PharVision Advisers, LLC filed a 13F-HR on April 22, 2026, reporting total equity holdings of $325,717 as of March 31, 2026, across 7 securities, all with sole voting and sole investment discretion. The portfolio consists of ACV Auctions Inc ($43,460; 10,250 shares), Alta Equipment Group Inc ($60,638; 11,292 shares), Community Health Sys Inc ($30,541; 10,388 shares), Melco Resorts and Entmnt Ltd ($69,029; 12,153 shares), Organogenesis Hldgs Inc ($38,636; 16,302 shares), TTEC Hldgs Inc ($32,690; 13,076 shares), and UWM Holdings Corporation ($50,723; 14,012 shares). No prior period data is available for comparison in this filing.
- ·All positions reported with sole voting power (SH: SOLE) and sole investment discretion.
- ·No put/call options or other shared power reported.
- ·Report period end: 2026-03-31; filed as of 2026-04-22.
22-04-2026
Gagnon Advisors, LLC filed its quarterly 13F-HR report on April 22, 2026, disclosing 22 equity holdings valued at a total of $135,928,828 as of March 31, 2026. The portfolio features sole voting power across all positions, with top holdings including Enterprise Products Partners L.P. ($12,860,946), Ameresco Inc. ($12,056,349), and Equinix Inc. ($10,503,272). No period-over-period changes are provided in this snapshot filing.
- ·Other notable holdings include CareDx Inc. with 532,892 shares valued at $9,251,005 and GeneDx Holdings Corp with 148,225 shares valued at $9,519,009.
- ·Portfolio managed under SEC file number 028-15744 and investment adviser ID 161-697.
22-04-2026
FSA Investment Group, LLC filed its 13F-HR report on April 22, 2026, disclosing institutional holdings as of March 31, 2026, consisting of 45 positions with a total market value of $248,441,254. The portfolio is heavily weighted towards ETFs, with the largest holding being SCHWAB STRATEGIC TR US LRG CAP ETF valued at $97,406,212, followed by VANGUARD INSTL INDEX FD 0-3 MO TREAS BIL at $61,099,025 and INVESCO EXCHANGE TRADED FD T S&P500 EQL WGT at $37,506,158. Individual stocks such as Apple Inc., NVIDIA Corporation, and Amazon.com Inc. are also held but represent smaller positions.
- ·All holdings reported with sole voting power (SH SOLE); no shared voting power or put/call options disclosed.
- ·Additional notable holdings include Apple Inc (1,073,351 USD, 4,233 shares), NVIDIA Corporation (1,076,920 USD, 6,175 shares), and Amazon.com Inc (497,765 USD, 2,390 shares).
22-04-2026
BankPlus Wealth Management LLC reported 117 equity holdings totaling $193,540,533 as of March 31, 2026, in its quarterly 13F-HR filing. The portfolio is diversified across stocks and ETFs, with the largest position in iShares Core S&P 500 ETF (81,004 shares valued at $52,926,084), followed by J.P. Morgan Core Plus Bond ETF ($16,740,105) and J.P. Morgan Income ETF ($9,262,097). No prior period data is available in this filing for comparison.
- ·Filing date: April 22, 2026
- ·Report period end: March 31, 2026
- ·All holdings reported as sole discretionary with no other manager or voting authority shares
22-04-2026
Pflug Koory, LLC filed its 13F-HR report disclosing total equity holdings valued at $218,249,761 across 419 positions as of March 31, 2026. Top holdings by value include Berkshire Hathaway Inc. Class A (21 shares, $15,080,940), Apple Inc. (49,935 shares, $12,672,927), Berkshire Hathaway Inc. Class B (20,330 shares, $9,742,136), Caterpillar Inc. (13,841 shares, $9,805,586), and Applied Materials Inc. (18,316 shares, $6,260,226). No period-over-period changes are provided in the filing.
- ·Filing date: April 22, 2026
- ·Report period end: March 31, 2026
- ·Filer address: 11312 Q St, Omaha, NE 68137
- ·All positions reported with sole voting power (SH SOLE)
22-04-2026
Caledonia Investments PLC filed its 13F-HR report on April 22, 2026, disclosing US equity holdings as of March 31, 2026, with a total portfolio value of $855934891 across 15 positions, all held with sole voting authority. Largest positions include Philip Morris International Inc ($116147715 for 702563 shares), Texas Instruments Inc ($100543800 for 518000 shares), and Microsoft Corp ($86725408 for 234317 shares). Other significant holdings are in Watsco Inc ($84668965), Fastenal Co ($64296899), and Charles Schwab Corp ($57415670).
- ·Report period end: March 31, 2026
- ·Filing date: April 22, 2026
- ·All holdings reported with sole voting authority
- ·No changes reported as of filing date
22-04-2026
Purple Innovation, Inc. filed definitive additional proxy materials for its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, at 10:00 a.m. Mountain Time via live audio webcast. The meeting includes Proposal 1: election of eight director nominees (S. Hoby Darling, Robert DeMartini, Gary DiCamillo, McNeil S. Fiske Jr., Adam Gray, Claudia Hollingsworth, D. Scott Peterson, and Erika Serow); Proposal 2: advisory approval of executive compensation; and Proposal 3: ratification of BDO USA, LLP as independent auditors for the year ending December 31, 2026. The Board recommends voting 'FOR' all proposals; full materials are available at https://annualgeneralmeetings.com/prpl2026.
- ·Virtual meeting requires advance registration at https://register.proxypush.com/PRPL by June 7, 2026, 5:00 p.m. Eastern Time.
- ·Paper or email copies of proxy materials can be requested by May 26, 2026, via 1-800-785-7782, https://annualgeneralmeetings.com/prpl2026, or cs@pacificstocktransfer.com.
- ·2025 Annual Report on Form 10-K is included in available proxy materials.
22-04-2026
TE Connectivity reported Q2 FY26 net sales of $4.74 billion, up 15% reported (7% organic) YoY, with record adjusted EPS of $2.73 (+24% YoY) and operating margin expansion to 22% adjusted. Record orders reached $5.3 billion (+25% YoY) across all businesses, while first-half free cash flow rose 17% YoY to $1.3 billion. Q3 FY26 guidance projects sales of ~$5 billion (+10% reported) and adjusted EPS of $2.83 (+17% YoY), reflecting continued momentum.
- ·GAAP operating margin expanded 200 bps YoY to 20%; adjusted to 22% (+130 bps).
- ·Cash and cash equivalents: $1,110 million as of March 27, 2026 (down from $1,255 million at Sep 26, 2025).
- ·Total employees including 10,000 engineers across ~130 countries.
22-04-2026
GE Vernova Inc. reported robust Q1 2026 results with total revenues increasing 16% YoY to $9,339 million from $8,032 million, driven by 25% growth in equipment sales to $5,254 million and 6% in services to $4,084 million. Net income attributable to GE Vernova surged to $4,745 million from $254 million, propelled by $4,762 million in other income (Note 19), though operating income grew more modestly to $179 million (+316% YoY) amid higher SG&A (+9%) and R&D expenses (+27%). Cash from operating activities rose to $5,188 million from $1,161 million, supporting $4,886 million in principal business acquisitions, with total assets expanding 20% QoQ to $75,612 million.
- ·Goodwill increased to $9,855 million from $4,439 million QoQ due to acquisitions.
- ·Long-term borrowings rose to $2,806 million from $265 million QoQ.
- ·Treasury common stock at cost increased to $(4,684) million from $(3,385) million QoQ amid $1,299 million repurchases.
- ·Dividends declared at $0.50 per common share, totaling $137 million.
22-04-2026
Travel + Leisure Co. reported Q1 2026 net revenue of $961 million, up 3% YoY from $934 million, with Vacation Ownership revenue increasing 6% to $798 million and Adjusted EBITDA surging 20% to $191 million, driven by 7% higher Gross VOI sales of $549 million, 5% tour growth, and 3% VPG increase to $3,321. However, Travel and Membership revenue fell 8% to $165 million with Adjusted EBITDA down 13% to $59 million due to lower transaction revenue and margin mix, while net cash from operations dropped to $38 million from $121 million and adjusted free cash flow turned neutral from $152 million. The company returned $128 million to shareholders via $87 million share repurchases and $41 million dividends, incurred $19 million in resort optimization impairments, and reaffirmed FY2026 Adjusted EBITDA guidance of $1,030-1,055 million.
- ·Leverage ratio below 3.2x as of March 31, 2026
- ·$832 million remaining share repurchase authorization as of March 31, 2026
- ·Q2 2026 guidance: Adjusted EBITDA $260-270 million, Gross VOI sales $660-690 million, VPG $3,200-3,250
- ·FY2026 guidance: Gross VOI sales $2.5-2.6 billion, VPG $3,175-3,275
- ·$325 million term securitization on March 26, 2026 at 5.11% weighted average coupon and 98% advance rate
- ·1.2 million shares repurchased at weighted average price of $72.51 per share
22-04-2026
BankUnited, Inc. reported Q1 2026 net income of $61.9 million ($0.83 diluted EPS), down $7.4 million or 10.7% QoQ from $69.3 million due to seasonal factors but up $3.4 million or 5.8% YoY from $58.5 million. Net interest margin declined 7 bps QoQ to 2.99% amid faster repricing of variable rate assets and seasonal NIDDA decline, though up 18 bps YoY; non-interest income fell $5.3 million QoQ to $24.7 million while non-interest expense decreased $5.4 million QoQ to $167.4 million. Total deposits grew with non-brokered up $277 million QoQ and $1.4 billion YoY, criticized/classified loans dropped 12% QoQ, and the company repurchased 1.3 million shares for $60 million while increasing dividends 6% to $0.33 per share.
- ·ROA 0.72% in Q1 2026, down 6 bps QoQ but up 4 bps YoY.
- ·ROE 8.1% in Q1 2026, down 80 bps QoQ and down 10 bps YoY.
- ·CET1 capital 12.2%, down 10 bps QoQ.
- ·Provision for credit losses $24.6 million in Q1 2026, down from $25.6 million QoQ but up from $15.1 million YoY.
- ·Net charge-offs $36.1 million in Q1 2026, up from $24.9 million QoQ.
- ·NPA ratio 0.79% at March 31, 2026, down from 1.08% at Dec 31, 2025.
22-04-2026
Employees Provident Fund Board filed a Form 13F-HR disclosing total holdings of 1074306485 USD across 24 positions in U.S. equities as of December 31, 2010. Key holdings include Microsoft Corp (3883133 shares valued at 108378242 USD), Johnson & Johnson (1790906 shares valued at 110767536 USD), and Wal Mart Stores Inc (1771128 shares valued at 95516933 USD). No changes in voting authority or performance comparisons are reported in this snapshot filing.
- ·Filing submitted on April 22, 2026, for period ending December 31, 2010.
- ·All positions reported with sole voting authority.
- ·Additional notable holdings: Intel Corp (2502381 shares, 52625072 USD), JPMorgan Chase & Co (984357 shares, 41756424 USD), Pfizer Inc (2041581 shares, 35748083 USD).
22-04-2026
Healthcare Services Group reported first quarter 2026 revenue of $462.8 million, up 3.4% YoY from $447.7 million, driven by new client wins and high retention, with net income rising to $26.1 million (from $17.2 million) and diluted EPS of $0.37 (from $0.23). Environmental Services revenue was $208.3 million at 12.1% margin and Dietary Services $254.5 million at 9.0% margin, while cost of services improved to 83.6% (goal 86%) and adjusted SG&A to 9.4% (goal 9.5-10.5%); however, cash flow from operations excluding payroll accrual declined to $23.4 million from $32.1 million YoY due to timing. The company repurchased $24.0 million in shares, holds $214.6 million in cash and marketable securities plus a $300 million credit facility, and reiterated mid-single-digit revenue growth outlook for 2026.
- ·Total assets increased to $814.8 million from $794.3 million at year-end 2025.
- ·Announced plan to repurchase $75.0 million of common stock through January 2027.
- ·Conference call on April 22, 2026; upcoming events: William Blair Non-Deal Roadshow (May 5-7), RBC Global Healthcare Conference (May 20), Benchmark Virtual Healthcare House Call (May 28), Baird Global Consumer, Technology and Services Conference (June 3).
22-04-2026
Employees Provident Fund Board filed a 13F-HR on April 22, 2026, disclosing US equity holdings as of June 30, 2010, with a total portfolio value of $799,134,542,000 across 25 positions held solely. Top holdings by value include Exxon Mobil Corp ($75,644,002,000; 1,325,460 shares), Procter & Gamble Co ($67,789,036,000; 1,130,194 shares), and Microsoft Corp ($62,526,569,000; 2,717,365 shares). This point-in-time report lists investments in major issuers like AT&T, Chevron, Pfizer, and Walmart, with no prior period comparisons provided.
- ·Report period end date: June 30, 2010
- ·Filing date: April 22, 2026
- ·All positions held as SOLE (no shared or other voting authority)
- ·Filer address: Menara KWSP, No.1 Persiaran Kwasa Utama, Kwasa Damansara, Seksyen U4, Shah Alam N8 40150
22-04-2026
Kyverna Therapeutics, Inc. issued press releases on April 20, 2026, announcing positive longer-term follow-up data from the Phase 2 portion of its KYSA-6 Phase 2/3 registrational trial of miv-cel (KYV-101) in patients with generalized myasthenia gravis (gMG), and on April 21, 2026, announcing positive primary analysis results from its KYSA-8 registrational trial of miv-cel in stiff person syndrome (SPS). The company will host a conference call at 7:00 a.m. Eastern Time on April 22, 2026, to review these results, with presentation slides furnished as Exhibit 99.1.
- ·Press releases dated April 20, 2026 (KYSA-6 gMG data) and April 21, 2026 (KYSA-8 SPS data).
- ·Conference call at 7:00 a.m. Eastern Time on April 22, 2026.
22-04-2026
Employees Provident Fund Board filed a 13F-HR report on April 22, 2026, disclosing its US equity holdings as of September 30, 2010, totaling $979628336 across 26 positions, all held with sole voting and investment discretion. Largest holdings include Exxon Mobil Corp at $93247783 (1509108 shares), Wal-Mart Stores Inc at $78558315 (1467831 shares), and Procter & Gamble Co at $73475724 (1225208 shares). No period-over-period changes, performance metrics, or other comparative data are provided.
- ·Holdings include Microsoft Corp with 3431354 shares valued at $84033859
- ·Pfizer Inc holding: 3377568 shares valued at $57992843
- ·Intel Corp holding: 2317394 shares valued at $44493965
- ·All positions reported as SOLE shared voting and discretion with 0 shared and 0 other
- ·Report covers period ending 09-30-2010
22-04-2026
Rafael Holdings' subsidiary, Cyclo Therapeutics, LLC, entered into an exclusive licensing agreement with MIT for U.S. Patent No. 12285440, covering the use of cyclodextrins in ApoE4-positive Alzheimer’s Disease patients, strengthening IP around Trappsol® Cyclo™. The ApoE4 variant is present in 50-70% of AD patients and is a key risk factor. Phase 3 results from the Transport NPC study for NPC1 are due in Q3 2026.
- ·U.S. Patent No. 12285440 covers cyclodextrins for improving myelination in ApoE4-positive AD
- ·Trappsol® Cyclo™ in pivotal Phase 3 trial for Niemann-Pick Disease Type C1 (NPC1), largest ever in NPC patients
Get daily alerts with 12 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 50 filings
More from: Dow Jones 30 Stocks SEC Filings
🇺🇸 More from United States
View all →April 15, 2026
US Pre-Market SEC Filings Roundup — April 15, 2026
US Pre-Market SEC Filings Roundup
April 15, 2026
US Merger & Acquisition SEC Filings — April 15, 2026
US Merger & Acquisition SEC Filings
April 15, 2026
US Corporate Board Director Changes SEC Filings — April 15, 2026
US Corporate Board Director Changes SEC Filings
April 15, 2026
US Executive Officer Management Changes SEC — April 15, 2026
US Executive Officer Management Changes SEC